Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis

Biochem Biophys Res Commun. 2004 Jul 16;320(1):165-9. doi: 10.1016/j.bbrc.2004.05.145.

Abstract

Fas is a member of the tumour necrosis factor receptor superfamily. Fas-mediated apoptosis is an essential mechanism protecting against skin cancer. Activation of Fas by specific ligand or agonistic antibodies leads to the formation of a membrane associated death-inducing signalling complex comprising aggregates of Fas, the Fas-associated death domain protein (FADD), and caspase-8. It has recently been suggested that activity of Fas is not only regulated by its cognate ligand but also by the association of this receptor with cholesterol-enriched lipid domains in the plasma membrane (lipid rafts). We report here that disruption of lipid rafts by cholesterol-depleting compounds (methyl-beta-cyclodextrin, filipin III, cholesterol oxidase, and mevastatin) leads to a spontaneous clustering of Fas in the non-raft compartment of the plasma membrane, formation of Fas-FADD complexes, activation of caspase-8, and apoptosis. We propose that in some cell types exclusion of Fas from lipid rafts leads to the spontaneous, ligand-independent activation of this death receptor, a mechanism that can potentially be utilized in anticancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Cell Line
  • Cholesterol / metabolism*
  • Cholesterol Oxidase / pharmacology
  • Cyclodextrins / pharmacology
  • Dose-Response Relationship, Drug
  • Filipin / pharmacology
  • Humans
  • Keratinocytes / cytology*
  • Keratinocytes / drug effects
  • Keratinocytes / metabolism*
  • Ligands
  • Lovastatin / analogs & derivatives*
  • Lovastatin / pharmacology
  • Membrane Fluidity / drug effects
  • Membrane Microdomains / drug effects
  • Membrane Microdomains / metabolism*
  • Membrane Microdomains / ultrastructure*
  • beta-Cyclodextrins*
  • fas Receptor / metabolism*

Substances

  • Cyclodextrins
  • Ligands
  • beta-Cyclodextrins
  • fas Receptor
  • methyl-beta-cyclodextrin
  • mevastatin
  • Filipin
  • Cholesterol
  • Lovastatin
  • Cholesterol Oxidase